CS212729B2 - Method of determining glycerol ester and fatty acid contents in aqueous media,and an enzymatic agent for carrying out the method - Google Patents
Method of determining glycerol ester and fatty acid contents in aqueous media,and an enzymatic agent for carrying out the method Download PDFInfo
- Publication number
- CS212729B2 CS212729B2 CS718751A CS875171A CS212729B2 CS 212729 B2 CS212729 B2 CS 212729B2 CS 718751 A CS718751 A CS 718751A CS 875171 A CS875171 A CS 875171A CS 212729 B2 CS212729 B2 CS 212729B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- glycerol
- lipase
- phosphate
- protease
- nadh
- Prior art date
Links
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 title claims abstract description 97
- 238000000034 method Methods 0.000 title claims abstract description 37
- 235000014113 dietary fatty acids Nutrition 0.000 title claims abstract description 19
- 229930195729 fatty acid Natural products 0.000 title claims abstract description 19
- 239000000194 fatty acid Substances 0.000 title claims abstract description 19
- -1 glycerol ester Chemical class 0.000 title claims abstract description 17
- 150000004665 fatty acids Chemical class 0.000 title claims abstract description 11
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 6
- 230000002255 enzymatic effect Effects 0.000 title claims description 8
- 239000012736 aqueous medium Substances 0.000 title description 5
- 102000004882 Lipase Human genes 0.000 claims abstract description 33
- 108090001060 Lipase Proteins 0.000 claims abstract description 33
- 239000004367 Lipase Substances 0.000 claims abstract description 33
- 239000004365 Protease Substances 0.000 claims abstract description 33
- 235000019421 lipase Nutrition 0.000 claims abstract description 33
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims abstract description 29
- 108091005804 Peptidases Proteins 0.000 claims abstract description 28
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims abstract description 24
- 235000019419 proteases Nutrition 0.000 claims abstract description 24
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 claims abstract description 23
- 239000007788 liquid Substances 0.000 claims abstract description 12
- 102000013009 Pyruvate Kinase Human genes 0.000 claims abstract description 11
- 108020005115 Pyruvate Kinase Proteins 0.000 claims abstract description 11
- 102000057621 Glycerol kinases Human genes 0.000 claims abstract description 10
- 108700016170 Glycerol kinases Proteins 0.000 claims abstract description 10
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 claims abstract description 10
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 claims abstract description 10
- GNGACRATGGDKBX-UHFFFAOYSA-N dihydroxyacetone phosphate Chemical compound OCC(=O)COP(O)(O)=O GNGACRATGGDKBX-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 9
- 108090000317 Chymotrypsin Proteins 0.000 claims abstract description 8
- 241000303962 Rhizopus delemar Species 0.000 claims abstract description 8
- 229960002376 chymotrypsin Drugs 0.000 claims abstract description 8
- 210000002966 serum Anatomy 0.000 claims abstract description 8
- 101000892220 Geobacillus thermodenitrificans (strain NG80-2) Long-chain-alcohol dehydrogenase 1 Proteins 0.000 claims abstract description 7
- 150000002148 esters Chemical class 0.000 claims abstract description 7
- 229930029653 phosphoenolpyruvate Natural products 0.000 claims abstract description 7
- 108010004032 Bromelains Proteins 0.000 claims abstract description 6
- 241000187392 Streptomyces griseus Species 0.000 claims abstract description 6
- 108090000631 Trypsin Proteins 0.000 claims abstract description 6
- 102000004142 Trypsin Human genes 0.000 claims abstract description 6
- 239000012588 trypsin Substances 0.000 claims abstract description 6
- 241000146387 Chromobacterium viscosum Species 0.000 claims abstract description 5
- 108010041921 Glycerolphosphate Dehydrogenase Proteins 0.000 claims abstract description 5
- 102000000587 Glycerolphosphate Dehydrogenase Human genes 0.000 claims abstract description 5
- 108090000526 Papain Proteins 0.000 claims abstract description 5
- 229940120503 dihydroxyacetone Drugs 0.000 claims abstract description 5
- 229940055729 papain Drugs 0.000 claims abstract description 5
- 235000019834 papain Nutrition 0.000 claims abstract description 5
- 102000016387 Pancreatic elastase Human genes 0.000 claims abstract description 4
- 108010067372 Pancreatic elastase Proteins 0.000 claims abstract description 4
- 230000003301 hydrolyzing effect Effects 0.000 claims abstract description 3
- 235000011187 glycerol Nutrition 0.000 claims description 35
- AWUCVROLDVIAJX-UHFFFAOYSA-N glycerol 1-phosphate Chemical compound OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 claims description 24
- 229950006238 nadide Drugs 0.000 claims description 16
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 claims description 15
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 claims description 15
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 claims description 14
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 claims description 14
- 230000007071 enzymatic hydrolysis Effects 0.000 claims description 13
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 claims description 13
- 230000008569 process Effects 0.000 claims description 11
- 230000007062 hydrolysis Effects 0.000 claims description 10
- 238000006460 hydrolysis reaction Methods 0.000 claims description 10
- DTBNBXWJWCWCIK-UHFFFAOYSA-N phosphoenolpyruvic acid Chemical compound OC(=O)C(=C)OP(O)(O)=O DTBNBXWJWCWCIK-UHFFFAOYSA-N 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 8
- 108090000790 Enzymes Proteins 0.000 claims description 8
- 229940088598 enzyme Drugs 0.000 claims description 8
- 150000003626 triacylglycerols Chemical class 0.000 claims description 5
- 102000035195 Peptidases Human genes 0.000 claims description 4
- 239000004615 ingredient Substances 0.000 claims description 3
- 108010079522 solysime Proteins 0.000 claims description 3
- XYZZKVRWGOWVGO-UHFFFAOYSA-N Glycerol-phosphate Chemical compound OP(O)(O)=O.OCC(O)CO XYZZKVRWGOWVGO-UHFFFAOYSA-N 0.000 claims description 2
- 241000588915 Klebsiella aerogenes Species 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 229940092559 enterobacter aerogenes Drugs 0.000 claims description 2
- 230000009466 transformation Effects 0.000 claims description 2
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 claims 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 claims 1
- 229950006790 adenosine phosphate Drugs 0.000 claims 1
- 238000012986 modification Methods 0.000 claims 1
- 230000004048 modification Effects 0.000 claims 1
- 238000010561 standard procedure Methods 0.000 claims 1
- 238000000844 transformation Methods 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 20
- 238000003556 assay Methods 0.000 abstract description 12
- 102000003855 L-lactate dehydrogenase Human genes 0.000 abstract description 11
- 108700023483 L-lactate dehydrogenases Proteins 0.000 abstract description 11
- 230000003287 optical effect Effects 0.000 abstract description 10
- 239000011541 reaction mixture Substances 0.000 abstract description 8
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract description 8
- WVVOBOZHTQJXPB-UHFFFAOYSA-N N-anilino-N-nitronitramide Chemical compound [N+](=O)([O-])N(NC1=CC=CC=C1)[N+](=O)[O-] WVVOBOZHTQJXPB-UHFFFAOYSA-N 0.000 abstract description 6
- 102000006746 NADH Dehydrogenase Human genes 0.000 abstract description 3
- 108010086428 NADH Dehydrogenase Proteins 0.000 abstract description 3
- 230000015572 biosynthetic process Effects 0.000 abstract description 3
- RXGJTUSBYWCRBK-UHFFFAOYSA-M 5-methylphenazinium methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2[N+](C)=C(C=CC=C3)C3=NC2=C1 RXGJTUSBYWCRBK-UHFFFAOYSA-M 0.000 abstract description 2
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 abstract description 2
- 230000007423 decrease Effects 0.000 abstract description 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 2
- 239000001257 hydrogen Substances 0.000 abstract description 2
- 229910001425 magnesium ion Inorganic materials 0.000 abstract description 2
- 235000013336 milk Nutrition 0.000 abstract description 2
- 210000004080 milk Anatomy 0.000 abstract description 2
- 239000008267 milk Substances 0.000 abstract description 2
- 230000003647 oxidation Effects 0.000 abstract description 2
- 238000007254 oxidation reaction Methods 0.000 abstract description 2
- 125000003831 tetrazolyl group Chemical group 0.000 abstract description 2
- DTBNBXWJWCWCIK-UHFFFAOYSA-K phosphonatoenolpyruvate Chemical compound [O-]C(=O)C(=C)OP([O-])([O-])=O DTBNBXWJWCWCIK-UHFFFAOYSA-K 0.000 abstract 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 13
- 239000000203 mixture Substances 0.000 description 13
- 239000007795 chemical reaction product Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 108010027597 alpha-chymotrypsin Proteins 0.000 description 3
- 150000002314 glycerols Chemical class 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- HWKRAUXFMLQKLS-UHFFFAOYSA-N 2-oxidanylidenepropanoic acid Chemical compound CC(=O)C(O)=O.CC(=O)C(O)=O HWKRAUXFMLQKLS-UHFFFAOYSA-N 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 108700040097 Glycerol dehydrogenases Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 108010059881 Lactase Proteins 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 108010059712 Pronase Proteins 0.000 description 1
- 101100519432 Rattus norvegicus Pdzd2 gene Proteins 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000009585 enzyme analysis Methods 0.000 description 1
- SBBWEQLNKVHYCX-JTQLQIEISA-N ethyl L-tyrosinate Chemical group CCOC(=O)[C@@H](N)CC1=CC=C(O)C=C1 SBBWEQLNKVHYCX-JTQLQIEISA-N 0.000 description 1
- SKAWDTAMLOJQNK-LBPRGKRZSA-N ethyl N-acetyl-L-tyrosinate Chemical compound CCOC(=O)[C@@H](NC(C)=O)CC1=CC=C(O)C=C1 SKAWDTAMLOJQNK-LBPRGKRZSA-N 0.000 description 1
- 229960004279 formaldehyde Drugs 0.000 description 1
- 235000019256 formaldehyde Nutrition 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229940116108 lactase Drugs 0.000 description 1
- 108010088076 lactate dehydrogenase 2 Proteins 0.000 description 1
- 229960001983 magnesium aspartate Drugs 0.000 description 1
- RXMQCXCANMAVIO-CEOVSRFSSA-L magnesium;(2s)-2-amino-4-hydroxy-4-oxobutanoate Chemical compound [H+].[H+].[Mg+2].[O-]C(=O)[C@@H](N)CC([O-])=O.[O-]C(=O)[C@@H](N)CC([O-])=O RXMQCXCANMAVIO-CEOVSRFSSA-L 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 229940117972 triolein Drugs 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/61—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving triglycerides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/02—Food
- G01N33/04—Dairy products
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/886—Streptomyces
- Y10S435/897—Streptomyces griseus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
- Y10S435/939—Rhizopus
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9890470A | 1970-12-16 | 1970-12-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS212729B2 true CS212729B2 (en) | 1982-03-26 |
Family
ID=22271481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS718751A CS212729B2 (en) | 1970-12-16 | 1971-12-16 | Method of determining glycerol ester and fatty acid contents in aqueous media,and an enzymatic agent for carrying out the method |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US3703591A (fr) |
| JP (2) | JPS549518B1 (fr) |
| AU (1) | AU475955B2 (fr) |
| BE (1) | BE776034A (fr) |
| BR (1) | BR7108185D0 (fr) |
| CA (1) | CA955161A (fr) |
| CH (2) | CH563404A5 (fr) |
| CS (1) | CS212729B2 (fr) |
| DE (1) | DE2162325C3 (fr) |
| ES (1) | ES395956A1 (fr) |
| FR (1) | FR2118454A5 (fr) |
| GB (1) | GB1373106A (fr) |
| IL (1) | IL38235A (fr) |
| IT (1) | IT972079B (fr) |
| NL (1) | NL180523C (fr) |
| SE (1) | SE389919B (fr) |
| ZA (1) | ZA717957B (fr) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2101796A1 (de) * | 1970-01-21 | 1971-08-05 | Baxter Laboratories Inc | Verfahren zur Bestimmung von Tnglycenden im Blutserum |
| AT324282B (de) * | 1972-06-19 | 1975-08-25 | Boehringer Mannheim Gmbh | Verfahren und reagens zur bestimmung von triglyceriden |
| CS164231B2 (fr) * | 1972-09-28 | 1975-11-07 | ||
| JPS49113695A (fr) * | 1973-02-27 | 1974-10-30 | ||
| AT339505B (de) * | 1974-03-14 | 1977-10-25 | Boehringer Mannheim Gmbh | Enzymatisches analysenverfahren |
| US3898130A (en) * | 1974-03-18 | 1975-08-05 | American Hospital Supply Corp | Rapid enzymatic hydrolysis of triglycerides |
| CA1029644A (fr) * | 1974-03-20 | 1978-04-18 | The Dow Chemical Company | Methode de determination de triglycerides et de glycol |
| US3884764A (en) * | 1974-03-25 | 1975-05-20 | Eastman Kodak Co | Method and composition for blood serum cholesterol analysis |
| CA1056282A (fr) * | 1974-03-25 | 1979-06-12 | Charles T. Goodhue | Elements multicouches pour le dosage du cholesterol |
| JPS50142090A (fr) * | 1974-04-30 | 1975-11-15 | ||
| JPS5169691A (en) * | 1974-06-07 | 1976-06-16 | Iatron Lab | Ketsuseichuno chuseishibosokuteiyoshaku |
| US4014744A (en) * | 1975-01-30 | 1977-03-29 | Miles Laboratories Inc. | Processes for measuring tri-, di- and monoglycerides |
| US4011045A (en) * | 1975-02-14 | 1977-03-08 | Bonderman Dean P | Turbidity reduction in triglyceride standards |
| JPS5217085A (en) * | 1975-07-30 | 1977-02-08 | Ono Pharmaceut Co Ltd | Method of quantitative determination of free fatty acids in serum usin g fatty acid activating enzymes |
| US4012287A (en) * | 1975-11-18 | 1977-03-15 | Dr. Bruno Lange Gmbh | Method and reagent for the quantitative analysis of triglycerides |
| US4045297A (en) * | 1975-12-15 | 1977-08-30 | Monsanto Company | Triglycerides determination method |
| DE2737286C2 (de) * | 1976-08-19 | 1985-05-02 | Eastman Kodak Co., Rochester, N.Y. | Mehrschichtige analytische Elemente für die Bestimmung von Triglyceriden und Glycerin in Flüssigkeiten |
| CA1100023A (fr) * | 1976-08-19 | 1981-04-28 | Charles T. Goodhue | Procede et composition pour le dosage du glycerol et des triglycerides |
| US4275152A (en) * | 1977-02-03 | 1981-06-23 | Eastman Kodak Company | Hydrolysis of protein-bound cholesterol esters |
| US4275151A (en) * | 1977-02-03 | 1981-06-23 | Eastman Kodak Company | Hydrolysis of protein-bound cholesterol esters |
| JPS6058746B2 (ja) * | 1977-09-22 | 1985-12-21 | 中外製薬株式会社 | 高級脂肪酸エステル |
| US4195126A (en) * | 1977-10-04 | 1980-03-25 | The Board Of Trustees Of The University Of Alabama | Albumin-dye complex for fatty acid determination |
| US4245041A (en) * | 1977-12-07 | 1981-01-13 | American Monitor Corporation | Triglycerides assay and reagents therefor |
| US4241178A (en) * | 1978-01-06 | 1980-12-23 | Eastman Kodak Company | Process and composition for the quantification of glycerol ATP and triglycerides |
| US4223090A (en) * | 1978-07-13 | 1980-09-16 | American Hospital Supply Corporation | Reagents for the enzymatic determination of triglycerides |
| DE2831580C2 (de) * | 1978-07-18 | 1980-09-18 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren und Reagens zur Bestimmung von Glycerin |
| DE2834704A1 (de) * | 1978-08-08 | 1980-02-21 | Boehringer Mannheim Gmbh | Verfahren zur quantitativen enzymatischen bestimmung von adp |
| US4302536A (en) * | 1978-08-15 | 1981-11-24 | Longenecker Robert W | Colorimetric immunoassay process |
| US4264589A (en) * | 1978-12-20 | 1981-04-28 | Felts James M | Separation of active α1 -acid glycoprotein and utilization in the lipoprotein lipase enzyme system |
| US4178285A (en) * | 1978-12-20 | 1979-12-11 | Felts James M | Separation of active α1 -acid glycoprotein and utilization in the lipoprotein lipase enzyme system |
| US4394445A (en) * | 1979-02-22 | 1983-07-19 | Nix Paul T | Enzymatic glyceride hydrolysis |
| US4259440A (en) * | 1979-05-21 | 1981-03-31 | Miles Laboratories, Inc. | Hydrolysis and assay of triglycerides |
| US4322496A (en) * | 1980-04-17 | 1982-03-30 | Eastman Kodak Company | Inhibition of lactate oxidase |
| US4309502A (en) * | 1980-06-30 | 1982-01-05 | Beckman Instruments, Inc. | Enzymatic assay for glycerol and triglycerides and a reagent for use therein |
| US4338395A (en) * | 1980-07-21 | 1982-07-06 | Technicon Instruments Corporation | Method for the analysis of triglycerides |
| EP0045031A1 (fr) * | 1980-07-22 | 1982-02-03 | Baker Instruments Corporation | Réactif pour la détection de glycérol et son application |
| US4394444A (en) * | 1982-06-21 | 1983-07-19 | Miles Laboratories, Inc. | Cofactor indicator compositions |
| JPS59140900A (ja) * | 1983-01-28 | 1984-08-13 | Toyo Jozo Co Ltd | 新規な酵素的高感度測定法 |
| JPS59196100A (ja) * | 1983-04-21 | 1984-11-07 | Amano Pharmaceut Co Ltd | グリセロ−ルの測定法および測定組成物 |
| US4626511A (en) * | 1985-05-13 | 1986-12-02 | Wayne State University | Composition for reducing turbidity in samples of biological fluids |
| US5310679A (en) * | 1985-05-13 | 1994-05-10 | Artiss Joseph D | Composition for reducing turbidity in samples of biological fluids |
| CN1466631A (zh) * | 2000-09-28 | 2004-01-07 | ������������ʽ���� | 蛋白质分解物的制备方法 |
| DE60224839T2 (de) | 2001-09-28 | 2009-01-29 | Arkray, Inc. | Verfahren zur lagerung von tetrazoliumverbindungen, dafür bestimmter stabilisator und nach dem verfahren aufbewahrte tetrazoliumverbindungsreagenzlösung |
| BR0317746A (pt) * | 2002-12-24 | 2005-11-22 | Stepan Co | Processo para se determinar o teor de glicerina de uma amostra de biodiesel |
| US20100296087A1 (en) * | 2007-05-31 | 2010-11-25 | Juergen Gailer | Method for assessing trace element related disorders in blood plasma |
| EP2857525B1 (fr) * | 2008-02-29 | 2019-04-10 | Oxford University Innovation Limited | Procédé pour déterminer le dosage adapté en statine. |
| US9817001B2 (en) | 2008-05-27 | 2017-11-14 | Boston Heart Diagnostics Corporation | Methods for determining LDL cholesterol treatment |
| US8470541B1 (en) | 2008-09-27 | 2013-06-25 | Boston Heart Diagnostics Corporation | Methods for separation and immuno-detection of biomolecules, and apparatus related thereto |
| EP2766728B1 (fr) | 2011-10-13 | 2017-09-06 | Boston Heart Diagnostics | Compositions et méthodes de traitement et de prévention d'une coronaropathie |
| US20140120559A1 (en) | 2012-10-26 | 2014-05-01 | Boston Heart Diagnostics Corporation | Diabetes panel |
| US9828624B2 (en) | 2013-07-24 | 2017-11-28 | Boston Heart Diagnostics Corporation | Driving patient compliance with therapy |
| EP3220810A4 (fr) | 2014-11-17 | 2018-05-16 | Boston Heart Diagnostic Corporation | Évaluation du risque de maladie cardiovasculaire |
-
1970
- 1970-12-16 US US98904A patent/US3703591A/en not_active Expired - Lifetime
-
1971
- 1971-10-13 ES ES295956A patent/ES395956A1/es not_active Expired
- 1971-11-12 FR FR7140669A patent/FR2118454A5/fr not_active Expired
- 1971-11-24 CA CA128,467A patent/CA955161A/en not_active Expired
- 1971-11-26 CH CH202475A patent/CH563404A5/xx not_active IP Right Cessation
- 1971-11-26 CH CH1720671A patent/CH566003A5/xx not_active IP Right Cessation
- 1971-11-26 IL IL38235A patent/IL38235A/en unknown
- 1971-11-26 ZA ZA717957A patent/ZA717957B/xx unknown
- 1971-11-30 GB GB5560971A patent/GB1373106A/en not_active Expired
- 1971-11-30 BE BE776034A patent/BE776034A/fr not_active IP Right Cessation
- 1971-12-02 AU AU36416/71A patent/AU475955B2/en not_active Expired
- 1971-12-09 BR BR8185/71A patent/BR7108185D0/pt unknown
- 1971-12-15 IT IT54760/71A patent/IT972079B/it active
- 1971-12-15 JP JP10112371A patent/JPS549518B1/ja active Pending
- 1971-12-15 SE SE7116097A patent/SE389919B/xx unknown
- 1971-12-15 DE DE2162325A patent/DE2162325C3/de not_active Expired
- 1971-12-16 NL NLAANVRAGE7117275,A patent/NL180523C/xx not_active IP Right Cessation
- 1971-12-16 CS CS718751A patent/CS212729B2/cs unknown
-
1978
- 1978-02-04 JP JP1106278A patent/JPS53114493A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE2162325B2 (de) | 1980-04-24 |
| IT972079B (it) | 1974-05-20 |
| ZA717957B (en) | 1972-08-30 |
| DE2162325A1 (de) | 1972-06-22 |
| CA955161A (en) | 1974-09-24 |
| DE2162325C3 (de) | 1980-12-11 |
| JPS549518B1 (fr) | 1979-04-25 |
| FR2118454A5 (fr) | 1972-07-28 |
| NL180523B (nl) | 1986-10-01 |
| IL38235A0 (en) | 1972-01-27 |
| BE776034A (fr) | 1972-03-16 |
| AU475955B2 (en) | 1976-09-09 |
| CH566003A5 (fr) | 1975-08-29 |
| NL180523C (nl) | 1987-03-02 |
| IL38235A (en) | 1974-10-22 |
| SE389919B (sv) | 1976-11-22 |
| GB1373106A (en) | 1974-11-06 |
| US3703591A (en) | 1972-11-21 |
| JPS53114493A (en) | 1978-10-05 |
| NL7117275A (fr) | 1972-06-20 |
| AU3641671A (en) | 1973-06-07 |
| ES395956A1 (es) | 1974-09-01 |
| BR7108185D0 (pt) | 1973-05-31 |
| CH563404A5 (fr) | 1975-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CS212729B2 (en) | Method of determining glycerol ester and fatty acid contents in aqueous media,and an enzymatic agent for carrying out the method | |
| Shimizu et al. | Enzymatic microdetermination of serum free fatty acids | |
| CA1125151A (fr) | Dosage des triglycerides et reactifs appropries | |
| US4543326A (en) | Stabilization of oxidase | |
| US4259440A (en) | Hydrolysis and assay of triglycerides | |
| US4242446A (en) | Method for determining a substance in a biological fluid and reagent combination for use in the method | |
| US3862009A (en) | Determination of triglycerides | |
| EP0695363B1 (fr) | Detection de substances biologiques | |
| US4056442A (en) | Lipase composition for glycerol ester determination | |
| EP0238352B1 (fr) | Procédé pour la détection sélective des nucléotides microbiens | |
| US3898130A (en) | Rapid enzymatic hydrolysis of triglycerides | |
| US4338395A (en) | Method for the analysis of triglycerides | |
| US4394445A (en) | Enzymatic glyceride hydrolysis | |
| US4066508A (en) | Process and reagent for determining triglycerides | |
| US4999289A (en) | Lipase, its production and use for assay of triglycerides | |
| US5962248A (en) | Quantitative determination method for chloride ions | |
| WO1980000260A1 (fr) | Determination de triglycerides et agents reactifs enzymatique | |
| US4309502A (en) | Enzymatic assay for glycerol and triglycerides and a reagent for use therein | |
| JPS6357040B2 (fr) | ||
| EP0089210B1 (fr) | Agent pour la détermination de la cholinestérase | |
| US4247633A (en) | Reagent for colorimetric determination of creative phosphokinase | |
| Korzenovsky | Bacterial metabolism of arginine | |
| GB2050601A (en) | An Improved Triglycerides Assay and Reagents Therefor | |
| JPH0220297A (ja) | コリンエステラーゼ活性の定量法及び定量用試薬 | |
| JPH05123194A (ja) | リパーゼ活性測定用組成物及びその組成物を用いるリパーゼ活性測定方法 |